Related Experiment Video

Updated: Aug 17, 2026

Development of a Negative Selectable Marker for Entamoeba histolytica
06:05

Development of a Negative Selectable Marker for Entamoeba histolytica

Published on: December 12, 2010

Entamoeba histolytica extract and interferon-gamma activation of macrophage-mediated amoebicidal function

E Ghadirian1, M Denis

  • 1Montreal General Hospital Research Institute, Quebec, Canada.

Immunobiology
|June 1, 1992
PubMed

Insights

Recombinant murine interferon-gamma (IFN-gamma) and E. histolytica extract (E.h.E.) synergistically activate macrophages for amoebicidal activity. This combined treatment is crucial for inducing significant cytotoxic effects against E. histolytica.

Area of Science:

  • Immunology
  • Parasitology

Background:

  • Macrophage activation is key to controlling parasitic infections.
  • Entamoeba histolytica is a significant human pathogen causing amoebiasis.

Purpose of the Study:

  • To investigate the combined effect of interferon-gamma (IFN-gamma) and E. histolytica extract (E.h.E.) on macrophage (M phi) activation.
  • To determine if these agents induce amoebicidal activity in macrophages.

Main Methods:

  • Peritoneal macrophages were isolated from C57BL/6 and A/J mice.
  • Macrophages were preincubated with recombinant murine IFN-gamma and/or E.h.E.
  • Amoebicidal activity against E. histolytica trophozoites was assessed.

Main Results:

  • Combined pretreatment with IFN-gamma and E.h.E. induced significant amoebicidal activity in macrophages from both mouse strains.
  • IFN-gamma or E.h.E. alone did not result in significant cytotoxic activity.
  • E.h.E. demonstrated a dose-dependent effect on macrophage activation in the presence of IFN-gamma.

Conclusions:

  • Synergistic activation of macrophages for amoebicidal function is achieved by combining IFN-gamma and E.h.E.
  • This combination therapy holds potential for controlling E. histolytica infections.

More Related Videos

Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection11:49

Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection

Published on: June 12, 2014

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

Related Concept Videos

Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...